Ivan Cokic1, Avinash Kali1, Hsin-Jung Yang1, Richard Tang1, Frank S Prato2, David Underhill1, and Rohan Dharmakumar1
1Cedars-Sinai Medical Center, Los Angeles, CA, United States, 2Lawson Health Research Institute, London, ON, Canada
Synopsis
Hemorrhagic myocardial infarctions (MI)
are associated with persistence of iron depositions in the chronic MI phase. These
iron deposits have been shown to lead to perpetual recruitment of new
monocytes/macrophages into the infarcted territory. Hemorrhagic MI is
accompanied by a persistent microvascular obstruction (PMO) but the converse is
not true. In this histologically validated cardiac MRI study we demonstrate
that even in the absence of hemorrhage, PMO per
se can lead to chronic iron-driven inflammatory response. Our findings are
expected and lend improved insight into the mechanisms driving heart failure in
infarction with PMO.PURPOSE
Persistent (or late)
microvascular obstruction (PMO) is an acute feature of myocardial infarctions (MI)
where microvascular blood flow to the MI territory is lost despite reperfusion;
it typically resolves in < 2 weeks, post-MI. PMOs are present in ~50% of
acute MIs. In the past two decades, advances in cardiac MRI (CMR) have
established that PMO is an independent predictor of adverse post-infarction
ventricular remodeling. Notably, a multi-national consortium recently reported
that the presence of PMO carries a 4-fold greater risk for major adverse
cardiovascular events (hospitalization /death) in the chronic period than acute
MI size. A frequent accompanying feature of PMO is reperfusion hemorrhage –
extravasation of blood into the interstitium. These recent observations led us
to report, which others later confirmed, that PMOs with hemorrhage lead to chronic
iron deposition (CID) and persistent inflammation at 8 weeks post MI; and that
this iron deposit is an independent marker of adverse remodeling in the chronic
phase of MI in animals and patients. In the present study, we hypothesized that
PMO, with or without reperfusion
hemorrhage, can resolve into iron deposition within chronic MI (CMI)
territories, and is associated with prolonged inflammation and adverse LV
remodeling.
METHODS
Canines
(n=33) were studied according to the protocols approved by the institutional Animal
Care and Use Committee. Seventeen dogs were subjected to ischemia-reperfusion
injury by occluding the left anterior descending (LAD) artery for 3 hours
followed by reperfusion (Reperfused Group, IR). The remaining 16 dogs were
subjected to permanent ligation of the LAD (Non-Reperfused Group, NR). All
canines underwent MRI at 5 days (acute) and 56 days (chronic) post-MI in a 3T
clinical MRI system (MAGNETOM Verio, Erlangen, Siemens Healthcare). ECG-triggered
breath-held 2D cine-SSFP images (20-25 cardiac phases, TR/TE=3.5/1.75 ms, flip
angle=70°, BW=930 Hz/pixel), T2*-weighted images (multiple gradient-echo,
TR=12ms, 6 TEs = 2.0ms–9.5ms with ΔTE=1.5ms, flip angle=10° and
BW=930Hz/pixel), and Late Gadolinium Enhancement images (IR-FLASH acquired
10-15 minutes following intravenous gadolinium infusion (Magnevist, Bayer
Healthcare Pharmaceuticals Inc., Wayne, NJ), optimal TI to null remote
myocardium, TR/TE=3.0/1.5 ms, flip angle=25°, BW=586 Hz/pixel) were acquired
along the short-axis direction covering the entire LV. Commonly used imaging
parameters for all the scans were: resolution = 1.4 x 1.4 x 6 mm3,. All
quantitative image analyses were performed using the cvi42 (Circle
Cardiovascular Imaging Inc.). LV structural remodeling was quantified using
end-diastolic sphericity index (EDSI) measurements from cine-SSFP images. Animals were
euthanized following the day 56 CMR scan and their hearts were excised for
further histological assessment of chronic iron-driven inflammatory
process.
RESULTS
In the reperfused group, 9 canines had PMO and hemorrhage with
subsequent chronic iron deposition (PMO+/T2*+), while 4 canines had no PMO,
hemorrhage, or chronic iron deposition (PMO/T2*-) [Fig A]. The remaining 4
canines had PMO without hemorrhage (PMO+/T2*), but all subsequently had chronic
iron deposition. In the non-reperfused group, 15 canines had PMO, and acute and
subsequent chronic iron deposition (NRPMO+/T2*+)Íž 1 canine had no PMO and acute or chronic iron deposition (NRPMO/T2*, Fig
A). In both groups, PMO volume was significantly associated with both acute and
chronic iron volumes (p<0.001, for all cases). In both groups, infarct and
iron volumes measured in both acute and chronic phases were significant
predictors of change in EDSI between acute and chronic phases (p<0.01 all
cases). Histological sections of infarcts (56 days post-MI) were positive for
presence of collagen (Elastin-modified Masson’s Trichrome stain) and revealed
co-localization of chronic iron depositions (Prussian Blue stain, CID) with
MAC387 (marker of newly recruited macrophages) and CD163 (marker indicating
iron-specific macrophage activation) [Fig B], as well as the proinflammatory
markers (IL-1β, TNF-α and MMP-9).
CONCLUSIONS
PMO per
se can lead to chronic iron-driven inflammatory response regardless of the presence or absence of
hemorrhage in the acute MI setting, and is an independent predictor of
adverse LV remodeling throughout the chronic post-MI phase.
Acknowledgements
No acknowledgement found.References
No reference found.